Literature DB >> 8105902

Estimating glucose absorption in peritoneal dialysis using peritoneal equilibration tests.

D M Bodnar1, S Busch, J Fuchs, M Piedmonte, M Schreiber.   

Abstract

To determine peritoneal dialysis patients' dietary energy requirements, the glucose absorbed from the dialysate needs to be quantified. The currently accepted method of estimating glucose absorption is based on the average glucose absorption of 7 continuous ambulatory peritoneal dialysis (CAPD) patients (Grodstein, 1981). Peritoneal equilibration test curves have shown that modality and transport characteristics affect glucose absorption. To test a more accurate procedure for estimating glucose absorption, we compared two different methods of determining the actual glucose absorption: Grodstein formula: (11.3 xa-10.9) liters of dialysate, where xa is the average glucose concentration, and the D/D0 formula: (1-D/D0)xi, where xi is the initial glucose instilled, using 4-hour D/D0 for CAPD and dwell time D/D0 for automated peritoneal dialysis (APD). Twenty-four-hour glucose absorption was measured in 50 CAPD patients and 17 APD patients. Absorption was calculated from the glucose remaining in the 24-hour spent dialysate. Wilcoxon sign rank statistical analysis showed the D/D0 formula results to be closer to actual glucose absorbed (CAPD: p = 0.0153; APD: p = 0.0001). The D/D0 formula is individualized for patients' modality and membrane characteristics and easy to calculate from readily available information.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8105902

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  3 in total

1.  Incremental peritoneal dialysis allows to reduce the time spent for dialysis, glucose exposure, economic cost, plastic waste and water consumption.

Authors:  Luca Nardelli; Antonio Scalamogna; Elisa Cicero; Giuseppe Castellano
Journal:  J Nephrol       Date:  2022-09-20       Impact factor: 4.393

2.  Comparison of Long-Term Outcomes between Peritoneal Dialysis Patients with Diabetes as a Primary Renal Disease or as a Comorbid Condition.

Authors:  Yutian Lei; Yifan Xiong; Lin Zhang; Hao Yan; Zhenyuan Li; Liou Cao; Jiaying Huang; Aiping Gu; Zhaohui Ni; Jiaqi Qian; Wei Fang
Journal:  PLoS One       Date:  2015-05-11       Impact factor: 3.240

Review 3.  Energy and protein requirements for children with CKD stages 2-5 and on dialysis-clinical practice recommendations from the Pediatric Renal Nutrition Taskforce.

Authors:  Vanessa Shaw; Nonnie Polderman; José Renken-Terhaerdt; Fabio Paglialonga; Michiel Oosterveld; Jetta Tuokkola; Caroline Anderson; An Desloovere; Laurence Greenbaum; Dieter Haffner; Christina Nelms; Leila Qizalbash; Johan Vande Walle; Bradley Warady; Rukshana Shroff; Lesley Rees
Journal:  Pediatr Nephrol       Date:  2019-12-16       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.